Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

UACR, UPCR provide indistinguishable prognostic information in chronic kidney disease (opens in a new tab)

medicalxpress.com · 2026-09-25

Short answerEvidenceSource

Short answer

Not supported

Not supported.

The study does not answer the story's main claims.

  • 4 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Not supported

The study doesn't address any of the story's claims. We found the paper, but it doesn't report the details the story leads with.

  • 4 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

4 claims in this story

Showing all 4 claimsChoose a verdict to focus the list.

Claim 1 of 4Not coveredIn a cohort of patients with chronic kidney disease, UACR and UPCR provide clinically indistinguishable prognostic information for kidney and cardiovascular outcomes.View evidenceHide evidence

As statedclinically indistinguishable

Why this verdict

The abstract-level profile supports that the paper compares UACR vs UPCR for predicting kidney failure, CKD progression, and cardiovascular outcomes in an established CKD cohort. However, it does not report results, effect estimates, comparative performance, or conclusions, so the headline claim that the two tests provide 'clinically indistinguishable' prognostic information is not verifiable at abstract depth. The headline outruns the available abstract evidence.

1

Study evidence

Study report (abstract) describing a head-to-head comparison of urinary albumin-creatinine ratio (UACR) versus urinary protein-creatinine ratio (UPCR) for prediction of kidney failure, chronic kidney disease (CKD) progression, and cardiovascular outcomes in an established CKD cohort.

“This study compares the clinical utility of the urinary albumin-creatinine ratio (UACR) vs the the urinary protein-creatinine ratio (UPCR) for prediction of kidney failure, chronic kidney disease (CKD) progression... in an established CKD cohort.”
2

Study evidence

Abstract reports an analysis in an established CKD cohort comparing the predictive/clinical utility of the urinary albumin-creatinine ratio (UACR) versus the urinary protein-creatinine ratio (UPCR) for cardiovascular outcomes.

“...for prediction of kidney failure, chronic kidney disease (CKD) progression, and cardiovascular outcomes in an established CKD cohort.”
Claim 2 of 4Not coveredAshish Verma and colleagues analyzed 3,742 Chronic Renal Insufficiency Cohort Study participants with paired UACRs and UPCRs from aliquots of the same 24-hour collection at baseline and followed them for a median of 15.0 years.View evidenceHide evidence

As stated3,742 participants; 15.0 years median follow-up

Why this verdict

The profile supports an established CKD cohort analysis comparing UACR and UPCR, but the abstract-level evidence does not provide the sample size, CRIC participant count, paired same-collection measurement details, baseline aliquot information, or 15.0-year median follow-up. These specifics cannot be verified from the supplied profile.

1

Study evidence

Study report (abstract) describing a head-to-head comparison of urinary albumin-creatinine ratio (UACR) versus urinary protein-creatinine ratio (UPCR) for prediction of kidney failure, chronic kidney disease (CKD) progression, and cardiovascular outcomes in an established CKD cohort.

“This study compares the clinical utility of the urinary albumin-creatinine ratio (UACR) vs the the urinary protein-creatinine ratio (UPCR) for prediction of kidney failure, chronic kidney disease (CKD) progression... in an established CKD cohort.”
2

Study evidence

Abstract reports an analysis in an established CKD cohort comparing the predictive/clinical utility of the urinary albumin-creatinine ratio (UACR) versus the urinary protein-creatinine ratio (UPCR) for cardiovascular outcomes.

“...for prediction of kidney failure, chronic kidney disease (CKD) progression, and cardiovascular outcomes in an established CKD cohort.”
Claim 3 of 4Not coveredThe researchers assessed kidney failure, CKD progression, and a composite of myocardial infarction, stroke, or heart failure hospitalization, and reported minimal differences in discrimination between UACR and UPCR.View evidenceHide evidence

As stated5-year AUC 0.894 vs 0.899; change in AUC less than 0.01; IDI less than 0.02

Why this verdict

The abstract-level profile supports that kidney failure, CKD progression, and cardiovascular outcomes were target outcome domains. But it contains no results, AUCs, IDI values, or discrimination comparisons. The stated minimal differences in discrimination and the quoted conclusion that either marker is valuable are therefore not verifiable at this depth.

1

Study evidence

Study report (abstract) describing a head-to-head comparison of urinary albumin-creatinine ratio (UACR) versus urinary protein-creatinine ratio (UPCR) for prediction of kidney failure, chronic kidney disease (CKD) progression, and cardiovascular outcomes in an established CKD cohort.

“This study compares the clinical utility of the urinary albumin-creatinine ratio (UACR) vs the the urinary protein-creatinine ratio (UPCR) for prediction of kidney failure, chronic kidney disease (CKD) progression... in an established CKD cohort.”
2

Study evidence

Abstract reports an analysis in an established CKD cohort comparing the predictive/clinical utility of the urinary albumin-creatinine ratio (UACR) versus the urinary protein-creatinine ratio (UPCR) for cardiovascular outcomes.

“...for prediction of kidney failure, chronic kidney disease (CKD) progression, and cardiovascular outcomes in an established CKD cohort.”
Claim 4 of 4Not coveredThe authors said that where UACR is unavailable or unaffordable, UPCR can be used without meaningful loss of information.View evidenceHide evidence

As statedwithout meaningful loss of information

Why this verdict

The supplied profile does not include any author recommendation or conclusion that UPCR can substitute for UACR when UACR is unavailable or unaffordable, nor does it report performance results needed to support 'without meaningful loss of information.' Because only abstract-level evidence is available and the profile explicitly notes no conclusions or comparative metrics, this practical substitution claim is not verifiable at this depth.

1

Study evidence

Study report (abstract) describing a head-to-head comparison of urinary albumin-creatinine ratio (UACR) versus urinary protein-creatinine ratio (UPCR) for prediction of kidney failure, chronic kidney disease (CKD) progression, and cardiovascular outcomes in an established CKD cohort.

“This study compares the clinical utility of the urinary albumin-creatinine ratio (UACR) vs the the urinary protein-creatinine ratio (UPCR) for prediction of kidney failure, chronic kidney disease (CKD) progression... in an established CKD cohort.”
2

Study evidence

Abstract reports an analysis in an established CKD cohort comparing the predictive/clinical utility of the urinary albumin-creatinine ratio (UACR) versus the urinary protein-creatinine ratio (UPCR) for cardiovascular outcomes.

“...for prediction of kidney failure, chronic kidney disease (CKD) progression, and cardiovascular outcomes in an established CKD cohort.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • At abstract depth, the supplied paper profile does not report results, directionality, effect estimates, comparative performance metrics, or conclusions for UACR versus UPCR.

    The story presents result-level claims such as clinically indistinguishable performance, AUC and IDI differences, and a substitution recommendation, but the supplied abstract-level profile says no such results or conclusions are available.

    From cohort-based prognostic comparison; cohort analysis

3 things the story did carry across
  • The paper compares the clinical or predictive utility of UACR versus UPCR for kidney failure and CKD progression in an established CKD cohort.
  • The paper also compares UACR versus UPCR for cardiovascular outcomes in the same CKD cohort.
  • The study is observational cohort-based prognostic research, not an intervention or treatment trial.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoCompare the predictive/clinical utility of urinary albumin-creatinine ratio (UACR) versus urinary protein-creatinine ratio (UPCR) for kidney failure and CKD progression outcomes in an established CKD cohort.cohort-based prognostic comparisonExpand

In plain English

Study report (abstract) describing a head-to-head comparison of urinary albumin-creatinine ratio (UACR) versus urinary protein-creatinine ratio (UPCR) for prediction of kidney failure, chronic kidney disease (CKD) progression, and cardiovascular outcomes in an established CKD cohort.

Key findings

No separate finding listed.

“This study compares the clinical utility of the urinary albumin-creatinine ratio (UACR) vs the the urinary protein-creatinine ratio (UPCR) for prediction of kidney failure, chronic kidney disease (CKD) progression... in an established CKD cohort.”
What this piece can’t prove
  • The abstract text provided does not report results, directionality, effect estimates, or comparative performance metrics for UACR versus UPCR.

2 further details could not be confirmed from the summary.

2human in vivoCompare the predictive/clinical utility of UACR versus UPCR for cardiovascular outcomes in the same established CKD cohort.cohort analysisExpand

In plain English

Abstract reports an analysis in an established CKD cohort comparing the predictive/clinical utility of the urinary albumin-creatinine ratio (UACR) versus the urinary protein-creatinine ratio (UPCR) for cardiovascular outcomes.

Key findings

No separate finding listed.

“...for prediction of kidney failure, chronic kidney disease (CKD) progression, and cardiovascular outcomes in an established CKD cohort.”
What this piece can’t prove

1 further detail could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref, Europe PMC · 40 candidate papers

And 34 more candidates considered.